Evaluation of persistent pulmonary infiltrates in pediatric oncology patients

Pediatric Blood and Cancer

Volumn 48, Issue 2, 2007, Pages 165-172

  Armenian, Saro H ^a   La Via, William V ^a,b   Siegel, Stuart E ^a,b   Mascarenhas, Leo ^a,b,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MS #54 ^*  (United States)

Author keywords

BAL; Biopsy; Infection; Infiltrate; Oncology; Pediatric; Pulmonary

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CHI SQUARE TEST; CHILD HOSPITALIZATION; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; LUNG BIOPSY; LUNG INFECTION; LUNG INFILTRATE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

BIOPSY; BONE MARROW TRANSPLANTATION; BRONCHOALVEOLAR LAVAGE; CHILD; HUMANS; LUNG; LUNG DISEASES; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845681691     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20747     Document Type: Article

References (56)

1. Ewig S, Torres A, Requelme R, et al. Pulmonary complications in patients with hematological malignancies treated at a respiratory ICU. Eur Respir J 1997;12:116-122.
2. Crawford SW, Hackman RC, Clark JG. Biopsy diagnosis and clinical outcome of persistent focal pulmonary lesions after marrow transplantation. Transplantation 1989;48:266-271.
3. Floreani AA, Sisson JH, Gurney J, et al. Thoracic complications related to bone marrow transplantation. Chest Surg Clin North Am 1999;9:139-165.
4. Murray PV, O'Brien MER, Padhani AR, et al. Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant 2001;27:967-971.
5. Baughman RP. The lung in an immunocompromised patient; infectious complications part 1. Respiration 1999;66:95-109.
6. Segal BH, Bow EJ, Menichetti F. Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin Am 2002;16:935-964.
7. Walsh TJ, Groll AH. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century. Tranpl Infect Dis 1999;1:247-261.
8. Chaoui D, Legrand O, Roche N, et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004;18:670-675.
9. Ewig S, Glasmacher A, Ulrich B, et al. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy. Chest 1998;14:441-451.
10. Fanfulla F, Locatelli F, Zoia MC, et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J 1997;10:2301-2306.
11. Davies L, Dolgin S, Kattan M. Morbidity and mortality of open lung biopsy in children. Pediatrics 1997;99:660-664.
12. Hayes-Jordan A, Benaim E, Richardson S, et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002;37:446-452.
13. Kornecki A, Shemie SD. Open lung biopsy in children with respiratory failure. Crit Care Med 2001;29:1247-1250.
14. Godfrey S, Avital A, Maayan C, et al. Yield from flexible bronchoscopy in children. Pediatr Pulmon 1997;23:261-269.
15. Huaringa AJ, Leyva FJ, Signes-Costa J, et al. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 2000;25:975-979.
16. Rock MJ. The diagnostic utility of bronchoalveolar lavage in immunocompetent children with unexplained infiltrates on chest radiograph. Pediatrics 1995;95:373-377.
17. White P, Bonacum JT, Miller CB. Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant 1997;20:681-687.
18. Hoffer FA, Gow K, Flynn P, et al. Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 2001;31:144-152.
19. Rath PM, Oeffelke R, Muller KD, et al. Non-value Aspergillus antigen detection in bronchoalveolar lavage fluids of patients undergoing bone marrow transplantation. Mycoses 1996;39:367-370.
20. Cheson BD, Samlowski WE, Tang TT, et al. Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer 1985;55:453-459.
21. Chuang ML, Lin IF, Tsai YH, et al. The utility of open lung biopsy in patients with diffuse pulmonary infiltrates as related to respiratory distress, it's impact on decision making by urgent intervention, and the diagnostic accuracy based on biopsy location. J Intens Care Med 2003;18:21-28.
22. LaChapelle KJ, Morin JE. Benefit of open lung biopsy in patients with respiratory failure. Can J Surg 1995;38:316-321.
23. Wagner JD, Stahler C, Knox S, et al. Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates. Am J Surg 1992;164:104-107.
24. Kim K, Lee MH, Kim J, et al. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Am J Hematol 2002;71:75-79.
25. Mason WH, Siegel SE, Tucker BL. Diagnostic open lung biopsy for diffuse pulmonary disease in immunocompromised pediatric patients. Am J Pediatr Hematol Oncol 1982;4:355-359.
26. Stefanutti D, Morais L, Fournet JC, et al. Value of open lung biopsy in immunocompromised children. J Pediatr 2000;137:165-171.
27. Cahill AM, Baskin KM, Kaye RD, et al. CT-guided percutaneous lung biopsy in children. J Vasc Interv Radiol 2004;15:955-960.
28. Hwang SS, Kim HK, Park SH, et al. The value of CT-guided percutaneous needle aspiration in immunocompromised patients with suspected pulmonary infection. AJR Am J Roentgenol 2000;175:235-238.
29. Jantunen E, Piilonen A, Volin L, et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867-871.
30. Wong PW, Stefanec T, Brown K, et al. Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies. Chest 2002;121:527-532.
31. Shaikh ZH, Torres HA, Walsh GL, et al. Open lung biopsy in BMT recipients has a poor diagnostic yield for specific diagnosis. Transpl Infect Dis 2002;4:80-84.
32. Gulbache HE, Pambuccian SE, Jessurun J, et al. Pulmonary nodular lesions in bone marrow transplant recipients: Impact of histologic diagnosis and patient management. Am J Clin Pathol 2004;121:205-210.
33. Ellis ME, Spence D, Bouchama A, et al. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Fungal Study Group. Scand J Infect Dis 1995;27:157-162.
34. Connolly JE, McAdams HP, Erasmus JJ, et al. Opportunistic fungal pneumonia. J Thorac Imaging 1999;14:51-62.
35. Marr KA, Patterson T, Denning D. Aspergillosis pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N Am 2002;16:875-894.
36. Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002;100:4358-4366.
37. Maschmeyer G, Link H, Hiddemann W, et al. Pulmonary infections in febrile neutropenic patients. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter trial. Cancer 1994;73:2296-2304.
38. Wald A, Leisenring W, van Burik JA, et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-1466.
39. Balfe D, Mohsenifar Z. Downward trends in bronchoscopies performed between 1991 and 1997. Chest 1999;116:238-242.
40. Lundberg BE, Davidson AJ, Burman WJ. Epidemiology of Pneumocystis carnii in the era of effective prophylaxis: The relative contribution of non-adherence and drug failure. AIDS 2000;14:2559-2566.
41. Rosen MJ. Overview of pulmonary complications. Clin Chest Med 1996;17:621-631.
42. Agostoni F, Atxori C, Angeli E, et al. Pneumocystis carnii diagnosis: An update. Int J Antimicrob Agents 2000;16:549-557.
43. Grandien M. Viral diagnosis by antigen detection techniques. Clin Diagn Virol 1996;5:81-90.
44. Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol 2004;15:iv329-iv335.
45. Ljungman P, von Dobeln L, Ringhom L, et al. The value of CMV and fungal PCR for monitoring for acute leukaemia and autologous stem cell transplant patients. Scand J Infect Dis 2005;37:121-127.
46. Bowden RA. Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center experience. Am J Med 1997;102:27-30.
47. Machado CM, Vilas Boas LS, Mendes AVA, et al. Low mortality rates related to respiratory virus infection after bone marrow transplantation. Bone Marrow Transplant 2003;31:695-700.
48. Schleuning M, Buxbaum-Conradi H, Jager G, et al. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolated from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoeitic stem cell transplants. Hematol J 2004;5:135-144.
49. Gosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000;25:751-755.
50. Machado CM, Boas LSV, Mendes AVA, et al. Use of Ostalmavir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004;34:111-114.
51. Maschmeyer G, Beinert T, Buschheidt D, et al. Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients. Ann Hematol 2003;82:S118-S126.
52. Maertens J, eldere JV, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002;186:1297-1306.
53. El-Mahallawy HA, Attia I, Ali-El-Din NH, et al. A prospective study on fungal infection in children. J Med Microbiol 2002;51:602-605.
54. Wheat LJ. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003;5:158-166.
55. DeLeon AL, Romero-Gutierrez G, Valenzuela CA, et al. Simplified PRISM III score and outcome in a pediatric intensive care unit. Pediatr Int 2005;47:80-83.
56. Schneider DT, Lemburg P, Sprock I, et al. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant 2000;25:1079-1086.